EyePoint Pharmaceuticals Inc
EYPT
Market Cap$501.72M
Close$
$-6.80
211.5% downside
Current Fair Value
211.5% downsideOvervalued by 211.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $501.72 Million |
|---|---|
| Enterprise Value | $441.66 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.32 |
| Beta | 1.41 |
| Outstanding Shares | 64,556,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -3.6 |
|---|---|
| PEG | -2.71 |
| Price to Sales | - |
| Price to Book Ratio | 1.22 |
| Enterprise Value to Revenue | 9.66 |
| Enterprise Value to EBIT | -3.78 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.12 |
Revenue Sources
No data
Insider Trades
ESG Score
No data